Literature DB >> 32761870

Psoriatic arthritis: A systematic review of non-HLA genetic studies and important signaling pathways.

Jingjing Chen1, Feng Yuan1, Xing Fan2, Yahua Wang1.   

Abstract

Psoriatic arthritis (PsA) is a common, chronic inflammatory disease with complex pathogenesis. In recent years, a number of susceptibility non-human leukocyte antigen (HLA) genes of PsA have been revealed, which also act as important factors in the pathogenesis of PsA as well as HLA genes. By searching the databases National Center for Biotechnology Information, Google and PubMed, 37 articles are included and 50 susceptibility non-HLA genes for PsA are presented, such as IL23A, TNIP1, TYK2, STAT4, IL12B, RUNX3 and TRAF3IP2. In these non-HLA genes, some are common genes shared with other diseases, whereas most of these susceptibility genes are related to the pathogenesis of PsA by activation or inhibition of the signaling pathways. Several signaling pathways possibly implicated in the pathogenesis of PsA are introduced in this paper, including the 2 mainly signaling pathways, IL23/Th17 signaling pathway and NF-κB signaling pathway, and the other involved signaling pathways, such as JAK-STAT signaling pathway and MAPK signaling pathway.
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  IL23/TH17 signaling pathway; NF-κB signaling pathway; psoriatic arthritis; signaling pathways; susceptibility non-HLA genes

Year:  2020        PMID: 32761870     DOI: 10.1111/1756-185X.13879

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  2 in total

1.  Causal Association Between Inflammatory Bowel Disease and Psoriasis: A Two-Sample Bidirectional Mendelian Randomization Study.

Authors:  Yajia Li; Jia Guo; Ziqin Cao; Jianhuang Wu
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 2.  Advances of Genomic Medicine in Psoriatic Arthritis.

Authors:  Carlos M Laborde; Leyre Larzabal; Álvaro González-Cantero; Patricia Castro-Santos; Roberto Díaz-Peña
Journal:  J Pers Med       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.